Hey Tim!  It's been a while buddy.  Hope you and your family are doing well, it's good to see you posting again.

 

ACAD has certainly been a poor investment for me, but I still believe the drug is ahead of it's time.  My son still takes it and the insurance companies seem to be more willing to approve it off label.  

 

I don't hold out much hope for the investment, but I do believe that at the end of the day the drug helps me son with negative symptoms of schizophrenia, and I hold out hope for those who suffer will see the drug approved for that indication.

 

I just hope ACAD gets to $29, my break even, so I can get out.  :)